TY - CHAP M1 - Book, Section TI - Interface between Psychiatry, Sleep, and Cancer A1 - Rose, Mary A1 - Robert, Rhonda A2 - Duffy, James D. A2 - Valentine, Alan D. PY - 2016 T2 - MD Anderson Manual of Psychosocial Oncology AB - Overwhelmingly, cancer patients report sleepiness as well as fatigue as among the most disabling side effects they experienced following cancer and its treatment. Approximately 30% to 60% of all cancer patients report sleep disturbance as a significant problem,1,2 with long-term cancer survivors being 40% more likely than the normative population to experience distress.3 At time of treatment, distress is even more significant; of those sampled with the Hamilton Anxiety Depression Scale in a general oncology waiting room in Argentina, 74.9% surpassed the cutoff score for anxiety, depression, or both.4 In another study of US patients awaiting chemotherapy, depression and anxiety were prevalent, with 45% of those sampled endorsing sleep disturbance.5 SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - hemonc.mhmedical.com/content.aspx?aid=1125785620 ER -